Psychopharmacological Trials in Cocaine Abuse Treatment

References

• Kleber H. D., Gawin F. H. Cocaine abuse: A review of current and experimental treatments, J. Grabowski, 1984; 111–129, NIDA Research Monograph Series 50, Cocaine: Pharmacology, Effects, and Treatment of Abuse 50
   Google Scholar
• Khantzian E. J. Self-selection and progression in drug dependence. Classic Contributions in the Addictions, H. Shaffer, M. E. Burglass. Brunner/Mazel, New York 1981; 154–160
   Google Scholar
• Rounsaville B. J., Weissman M. M., Kleber H., Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1982; 39: 151–156
   PubMed Web of Science ®Google Scholar
• Weiss R. D., Mirin S. M., Michael J. L. Psychopathology in Chronic Cocaine Abusers. Paper Presented at the 136th Annual Meeting of the American Psychiatric Association, New York, May, 41983
   Google Scholar
• Gawin F. H., Kleber H. D. Cocaine abuse in a treatment population: Patterns and diagnostic distinctions, E. H. Adams, N. J. Kozel, 1985; 182–192, NIDA Research Monograph Series 61, Cocaine Use in America: Epidemiologic and Clinical Perspectives
   Google Scholar
• Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in chronic cocaine abusers. Arch. Gen. Psychiatry 1986; 43: 107–113
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Cocaine abuse treatment: An open pilot trial with lithium and desipramine. Arch. Gen. Psychiatry 1984; 41: 903–910
   PubMed Web of Science ®Google Scholar
• Khantzian E. J., Gawin F. H., Riordan C., Kleber H. D. Methylphenidate treatment of cocaine dependence-A preliminary report. J. Substance Abuse Issues 1984; 1: 107–112
   PubMedGoogle Scholar
• Cohen S. Cocaine Today. American Council on Drug Education, New York 1981; 1–46
   Google Scholar
• Ellinwood E. H. Amphetamine and cocaine. Psychopharmacology in the Practice of Medicine, M. E. Jarvik. Appleton-Century-Crofts, New York 1977; 467–476
   Google Scholar
• Colpaert F. C., Niemegeers C. J., Janssen P. A. Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol. Biochem. Behav. 1979; 10: 535–546
   Google Scholar
• Kokinidis L., Zacharko R. Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm. Psychopharmacology 1980; 68: 73–76
   Google Scholar
• Leith N. J., Barrett R. J. Amphetamine and the reward system: Evidence for tolerance and post-drug depression. Psychopharmacology 1976; 46: 19–25
   Google Scholar
• Leith N. J., Barrett R. J. Self-stimulation and amphetamine: Tolerance to d and isomers and cross tolerance to cocaine and methylphenidate. Psychopharmacology 1981; 74: 23–28
   PubMed Web of Science ®Google Scholar
• Simpson D. Depressed Rates of Self-Stimulation Following Chronic Amphetamine in the Rat: Elevation of These Depressed Rates by Desmethylimipramine. Paper Presented at the Eastern Psychological Association. April, 191974
   Google Scholar
• Simpson D. M., Annau Z. Behavioral withdrawal following several psychoactive drugs. Pharmacol. Biochem. Behav. 1977; 7: 59–64
   Google Scholar
• Willner P. The validity of animal models of depression. Psychopharmacology 1985; 83: 1–16
   Google Scholar
• Kokinidis L., Zacharko R. M., Predy P. A. Post-amphetamine depression of self-stimulation responding from the substantianigra; Reversal by tricyclic antidepressants. Pharmacol. Biochem. Behav. 1980; 13: 379–383
   Google Scholar
• Banerjee S. P., Sharman V. K., King-Cheung L. S., Chanda S. K., Rigg S. J. Cocaine and d-amphetamine induce changes in central B-adrenoceptor sensitivity: Effects of acute and chronic drug treatment. Brain Res. 1979; 175: 119–130
   PubMedGoogle Scholar
• Borison R. L., Hitri A., Klawans H. L., Diamond B. I. A new animal model for schizophrenia: Behavioral and receptor binding studies. Catecholamines: Basic and Clinical Frontiers, E. Usdin. Pergamon, New York 1979
   Google Scholar
• Chanda S. K., Sharma V. K., Banerjee S. P. B-adrenoceptor sensitivity following psychotropic drug treatment. Catecholamines: Basic and Clinical Frontiers, E. Usdin. Pergamon, New York 1979
   Google Scholar
• Pert A. C., Rosenblatt J., Squillace K. M., Post R. H. Effect of chronic cocaine on behavior and cyclic amp in cerebrospinal fluid of rhesus monkeys. Commun. Psychopharmacol. 1979; 3: 143–152, Unpublished Manuscript, cited in Post, R. M., Smith, S. S., Squillace, K. M., and Tallman, J. P.
   Google Scholar
• Taylor D. L., Ho B. T., Fagan J. D. Increased dopamine receptor binding in rat brain by repeated cocaine injection. Commun. Psychopharmacol. 1979; 3: 137–142
   PubMedGoogle Scholar
• Charney D. S., Menkes D. B., Heninger G. R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch. Gen. Psychiatry 1981; 38: 1160–1180
   PubMed Web of Science ®Google Scholar
• Koide T., Matshushita H. An enhanced sensitivity of muscarinic cholinergic receptors associated with dopaminergic receptor sub-sensitivity after chronic antidepressant treatment. Life Sci. 1981; 28: 1139
   PubMed Web of Science ®Google Scholar
• Nabor D., Wirz-Justive A., Kutka M. S., Wehr T. A. Dopamine receptor binding in rat striatum: Ultradian rhythm and its modification by chronic imipramine. Psychopharmacology 1980; 68: 1–5
   Google Scholar
• Wise R. A. Neural mechanisms of the reinforcing action of cocaine. NIDA Research Monograph Series 1984; 50: 15–33
   PubMedGoogle Scholar
• Tennant F. S., Rawson R. A. Cocaine and amphetamine dependence treated with desipramine. Problems of Drug Dependence. National Institute of Drug Abuse Research. 1982
   Google Scholar
• Tennant F. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence, NIDA Research Monograph Series, In Press
   Google Scholar
• Gold M. S., et al. Cocaine Withdrawal: Efficacy of Tyrosine. Paper Presented at the 13th Annual Meeting of the Society for Neuroscience, Boston, November, 6–111983
   Google Scholar
• Kramer J. C., Fischman V. S., Littlefield D. C. Amphetamine abuse pattern and effects of high doses taken intravenously. J. Am. Med. Assoc. 1967; 201: 305–309
   PubMed Web of Science ®Google Scholar
• Rosecan J. The Treatment of Cocaine Abuse with Imipramine, L-Tyrosine, and L-Tryptophan. Presented at the VII World Congress of Psychiatry, ViennaAustria, July, 14–191983
   Google Scholar
• Rosecan J. The treatment of cocaine abuse with imipramine. 1985, L-tyrosine, and L-tryptophan: An open trial with 25 patients, Submitted
   Google Scholar
• Rosecan J. Imipramine blockade of cocaine euphoria with double-blind challenge. 1985, Submitted
   Google Scholar
• Rowbotham M. C., Jones R. T., Benowit N. L., Jacob P., III. Trazodone-oral cocaine interactions. Arch. Gen. Psychiatry 1984; 41: 895–899
   PubMed Web of Science ®Google Scholar
• Cronson A. J., Flemenbaum A. Antagonism of cocaine highs by lithium. Am. J. Psychiatry 1978; 135: 856–857
   PubMed Web of Science ®Google Scholar
• Gold H. S., Byck R. Lithium, naloxone, endorphins, and opiate receptors: Possible relevance to pathological and drug-induced manic-euphoric states in man. The International Challenge of Drug Abuse. Superintendent of Documents, U.S. Government Printing Office, Washington, DC 1978; 192–209, National Institute of Drug Abuse Research Monograph Series 19, DHEW Pub. No. (ADM) 78–654
   Google Scholar
• Mandell A. J., Knapp S. Neurobiologjcal antagonism of cocaine by lithium. Cocaine and Other Stimulants, E. H. Ellinwood, M. M. Kilby. Plenum, New York 1976; 187–200
   Google Scholar
• Angrist B., Gershon S. Variable attenuation of amphetamine effects by lithium. Am. J. Psychiatry 1979; 136: 806–810
   PubMed Web of Science ®Google Scholar
• Resnick R. B., Washton A. M., LaPlaca R. W., Ston-Washton N. Lithium Carbonate as a Potential Treatment for Compulsive Cocaine Use: A Preliminary Report. Presented at the Thirty-Second Annual Convention and Scientific Meeting of the Society of Biological Psychiatry, TorontoCanada, April 28-May, 1977, 1
   Google Scholar
• Gawin F. H., Kleber H. D. Methylphenidate treatments of non-ADD cocaine abusers. Am. J. Drug Alcohol Abuse 1985; 11: 193–197
   PubMed Web of Science ®Google Scholar
• DeWit H., Wise R. A. Blockade of cocaine reinforcement in rats with the dopamine receptor pimozide, but not with the noradrenergic blockers phentolamine and phenoxybenzamine. Can. J. Psychol. 1977; 31: 195–203
   PubMed Web of Science ®Google Scholar
• Jarbe T. Cocaine as a discriminative cue in rats: Interactions with neuroleptics and other drugs. Psychopharmacology 1978; 59: 183–187
   Google Scholar
• Spyraki C., Fibiger H. C., Phillips A. C. Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 1982; 253: 195–203
   PubMed Web of Science ®Google Scholar
• Fraenkel H. M., Van Beek-Verbeek G., Fabriek A., Van Ree J. M. Desglycinamide-arginine-vasopressin and ambulant methadone-Detoxification of heroin addicts. Alcohol Alcoholism 1983; 18(4)331–335
   Google Scholar
• Anker A. L., Crowley T. J. Use of contingency in speciality clinics for cocaine abuse. Problems of Drug Dependence 1981, L. S. Harris. Committee on Problems of Drug Dependence Inc. 1982; 452–459, National Institute for Drug Abuse Research Monograph 41
   Google Scholar
• Siegel R. K. Cocaine smoking. J. Psychoactive Drugs 1982; 14: 271–359
   PubMed Web of Science ®Google Scholar
• Washton A. Data presented at the 23rd annual meeting of the American College of Neuropharmacology. December, 101984
   Google Scholar